Captopril vs Pembrolizumab

Captopril vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Captopril and Pembrolizumab.

Mechanism of Action

Captopril: First orally active ACE inhibitor; contains thiol group that binds zinc at ACE active site.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Captopril — 1.9 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Captopril — C9H15NO3S.

Molecular Weight: Captopril — 217.2850 g/mol.

Type: Captopril — Small molecule; Pembrolizumab — Antibody.